Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Fenoprofen, 600 mg, three times daily, was compared with phenylbutazone, 100 mg, three times daily, in 30 patients suffering from ankylosing spondylitis in a double-blind cross-over study. Assessments were made after an initial washout period and after each month-long treatment period. Phenylbutazone significantly improved morning stiffness, finger-to-floor distance, chest expansion, overall joint pain, spinal pain, the physician's assessment of disease activity and ESR. Only chest expansion was significantly improved by fenoprofen, and phenylbutazone was significantly better than fenoprofen in its effects on finger-to-floor distance, morning stiffness, overall joint pain, spinal pain and the physician's assessment of disease activity. Side-effects were of a minor nature apart from one patient who developed rectal bleeding on phenylbutazone which recurred on rechallenging.

Original publication

DOI

10.1093/rheumatology/19.4.260

Type

Journal article

Journal

Rheumatology and rehabilitation

Publication Date

11/1980

Volume

19

Pages

260 - 263

Keywords

Humans, Spondylitis, Ankylosing, Phenylpropionates, Fenoprofen, Phenylbutazone, Drug Administration Schedule, Double-Blind Method, Adult, Middle Aged, Female, Male, Clinical Trials as Topic